Logiscreen

Inotiv Inc

$0.17
Market Cap 5.71M
ROE -74.7%
Gross Margin 21.0%
Debt/Equity 6.3
Current Ratio 0.3
Revenue QoQ -5.4%
EPS QoQ 1.1%
F-Score 2

About

Inotiv, Inc. is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market.

Exchange
NASDAQ
Sector
Healthcare
Industry
Diagnostics & Research

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-0.03
vs median 31.50
P/B
0.04
vs median 2.17
ROE
-0.75
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics